0960B |
Cannabinoids Panel, Blood |
0960FL |
Cannabinoids Panel, Fluid |
0960ME |
Cannabinoids Panel (Qualitative), Meconium |
0960SP |
Cannabinoids Panel, Serum/Plasma |
0960TI |
Cannabinoids Panel, Tissue |
0962B |
Cannabidiol, Blood |
0962SP |
Cannabidiol, Serum/Plasma |
0964U |
Cannabinoid Metabolite, Urine |
0966B |
Cannabis Plus Recent Use Markers, Blood |
0966SP |
Cannabis Plus Recent Use Markers, Serum/Plasma |
1029SP |
CBD, Serum/Plasma |
1320B |
Colchicine, Blood |
1320SP |
Colchicine, Serum/Plasma |
1320TI |
Colchicine, Tissue |
1407B |
Cyclohexane, Blood |
1409B |
Cyclohexanone, Blood |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9356B |
Cannabinoids Screen, Blood |
9356FL |
Cannabinoids Screen, Fluid |
9356SP |
Cannabinoids Screen, Serum/Plasma |
9356U |
Cannabinoids Screen, Urine |